A question for investors today is how they want to react to President Trump threatening to put more tariffs on Chinese goods. Let’s explore the issue with the...
Our call of the day is a bullish one from Jonathan Golub, chief U.S. equity strategist at Credit Suisse Securities, who tells MarketWatch that he’s got a...
As the Trump administration and Democratic lawmakers talk up their preliminary agreement on infrastructure, each side says it will include money to improve...
They deliver energy, electronics, and expediency. Should your portfolio embrace their stocks, too? Read More...
Drugmaker Mylan missed Wall Street estimates for quarterly revenue, hurt by restructuring at its Morgantown plant in West Virginia and a stronger dollar,. Read...
Mallinckrodt Pharmaceuticals rose as much as 16.4% but opened lower after first-quarter earnings beat projections and the company raised its guidance. Read...
Mallinckrodt Pharmaceuticals rose as much as 9% but opened lower after first-quarter earnings beat projections and the company raised its guidance. Read more...
Mallinckrodt Pharmaceuticals soared in premarket trading Tuesday after the company released first-quarter earnings that beat Wall Street's expectations...
High-Growth Tech Stocks' Recent Performance(Continued from Prior Part)Square’s returnsShares of mobile payment processing company Square (SQ) have fallen...
These two tech stocks look cheap at the moment and could deliver huge returns for risk-tolerant investors. Read More...
